Investigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly(ethylene glycol) micro/nano-particles in osteoblast cells

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 557-566

  Wang, Weijia ^a   Zhou, Shaobing ^a   Guo, Laiyang ^a   Zhi, Wei ^a   Li, Xiaohong ^a   Weng, Jie ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

Author keywords

Cytotoxicity; Drug delivery; Endocytosis; Intracellular trafficking; Nanoparticles

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FLUORESCEIN ISOTHIOCYANATE; MACROGOL; MACROGOL DERIVATIVE; MICROSPHERE; NANOPARTICLE; NANOSPHERE; POLY DEXTRO,LEVO LACTIDE POLY(ETHYLENE GLYCOL); UNCLASSIFIED DRUG; DRUG CARRIER; POLY(ETHYLENEGLYCOL LACTIDE); POLY(ETHYLENEGLYCOL-LACTIDE); POLYESTER;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CELL SURVIVAL; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOCYTOSIS; EVAPORATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; LASER DIFFRACTION; NANOANALYSIS; NANOFABRICATION; NONHUMAN; OSTEOBLAST; PARTICLE SIZE; POLYMERIZATION; QUANTITATIVE ANALYSIS; RAT; SCANNING ELECTRON MICROSCOPY; SPECTROFLUOROMETRY; STRUCTURE ANALYSIS; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; MATERIALS TESTING; METABOLISM; NANOMEDICINE; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

RATTUS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; MATERIALS TESTING; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MICROSPHERES; NANOMEDICINE; NANOSPHERES; OSTEOBLASTS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; RATS;

EID: 79952118056     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Moghimi SM, Hunter AC, Murray JC. Long-circulating and targetspecific nanoparticles: theory to practice. Pharm Rev. 2001;53: 283-318.
2. Riezman H, Woodman PG, Meer G, Marsh M. Molecular mechanisms of endocytosis. Cell. 1997;91:731-738.
3. Johannes L, Lamaze C. Clathrin-dependent or not: is it still the question? Traffic. 2002;3:443-451.
4. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37-44.
5. Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharm Rev. 2006;58:32-45.
6. Lamaze C, Schmid SL. The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol. 1995;7:573-580.
7. Langer R. Drug delivery and targeting. Nature. 1998;392:5-10.
8. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161-171.
9. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharm Ther. 2008;83:761-769.
10. Jensen KD, Nori A, Tijerina M, Kopeckova P, Kopecek J. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. J Control Release. 2003;87:89-105.
11. Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res. 2003;20:212-220.
12. Meng W, Parker TL, Kallinteri P, et al. Uptake and metabolism of novel biodegradable poly(glycerol-adipate) nanoparticles in DAOY monolayer. J Control Release. 2006;116:314-321.
13. Zhou SB, Deng XM, Li XH. Investigation on a novel core-coated microspheres protein delivery system. J Control Release. 2001;75 (1-2):27-36.
14. Zhou SB, Deng XM,Yang H. Biodegradable copolymer of poly (ethylene glycol)-co-poly (e-caprol actone):characterization and its use in controlled release system. Biomaterials. 2003;24(20): 3563-3570.
15. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci. 2006;103:6315-6320.
16. Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V. Codelivery of hydrophobic and hydrophilic drugs from nanoparticle- aptamer bioconjugates. Chem Med Chem. 2007;2:1268-1271.
17. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;28:869-876.
18. Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A. 2008;19: 2586-2591.
19. Wei XW, Gong CY, Gou ML, Fu SZ, Guo QF, Qian ZY. Biodegradable poly(,epsilon.-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm. 2009;381:1-18.
20. Gou ML, Zheng XL, Men K, Zhang J, Wang BL, Qian ZY. Self- assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm Res. 2009;26:2164-2173.
21. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endolysosomal escape of poly (D,L-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 2002;16:1217-1226.
22. Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm. 2002;244:105-115.
23. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105-114.
24. Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 2009;30:2790-2798.
25. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res. 2004;10:3708-3716.
26. Kim DW, Kim SY, Kim HK, Kim SW, Shin SW, Kim JS. Multicenter phase II trial of Genexol-PM, a novel cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced nonsmall- cell lung cancer. Ann Oncol. 2007;18:2009-2014.
27. Lee KC, Chung HC, Im SA, Park YH, Kim CS, Kim SB. Multicenter phase II trial of Genexol-PM, a cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat. 2008;108:241-250.
28. Deng X, Zhou S, Li X, Zhao J, Yuan M. In vitro degradation and release profiles for poly-dl-lactide-poly(ethylene glycol) microspheres containing human serum albumin. J Control Release. 2001;71: 165-173.
29. Xu WS, Wood-Adams PM, Robertson CG. Measuring local viscoelastic properties of complex materials with tapping mode atomic force microscopy. Polymer. 2006;47:4798-4810.
30. Chan JM, Zhang LF, Yuet KP, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30: 1627-1634.
31. Sandstrom K, Hakansson L, Lukinius A, Venge P. A method to study apoptosis in eosinophils by flow cytometry. J Immunol Methods. 2000; 240:55-68.
32. Suh H, Jeong B, Liu F, Kim SW. Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res. 1998;15: 1495-1498.
33. Hu Y, Xie JW, Tong YW, Wang CH. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release. 2007;118:7-17.
34. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface- modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release. 2005;102:373-381.
35. Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov. 2005;4:381-385.
36. Wattendorf U, Merkle HP. PEG-ylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci. 2008;97: 4655-4669.
37. Zauner W, Farrow NA, Haines AM. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release. 2001;71:39-51.
38. Foster KA, Yazdanian M, Audus KL. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol. 2001;53:57-66.
39. Grabe M, Oster G. Regulation of organelle acidity. J Gen Physiol. 2001; 117:329-344.
40. Watson P, Jones AT, Stephens DJ. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv Drug Deliv Rev. 2005;57:43-61.
41. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol. 2000;18(1):7-33.
42. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20.
43. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6:319-327.
44. Prego C, Garcia M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. J Control Release. 2005;101:51-62.
45. Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1-27.